This opportunity is no longer accepting applications.
grant PAR-21-237

NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)

This grant opportunity invites applications for clinical trials focused on testing the effectiveness of various medical interventions in the field of neurological disorders and stroke. Researchers can propose studies evaluating drugs, medical devices, surgery, and behavioral or rehabilitation therapies, in line with the goals of the National Institute of Neurological Disorders and Stroke (NIND…

The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for investigator-initiated efficacy clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address questions within the mission and research interests of…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Neurological Disorders and Stroke
Program: SBIR

Dates

Opportunity Released: May 19, 2021
Open for Submission: May 19, 2021
Submission Deadline: January 9, 2025
Application Window Closes: January 9, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.